Abstract
The present disclosure relates to compounds of Formula (Ia) and (Ib): or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.
Full Text
What is claimed is:
The present disclosure relates to compounds of Formula (Ia) and (Ib):
or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.
Timeline
Filed
03/13/2026Published
07/16/2026Granted
Not AvailableIPC Codes(9)
A61K 31/4439:containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K 31/465)
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 9/48:Preparations in capsules, e.g. of gelatin, of chocolate